Clinical trial

β-Cell Function in Schizophrenic Subjects on Atypical Antipsychotic drugS

NCT00528359

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2005-10-01

PhaseN/A

Study timeline

Study start (unknown)2005-10-01Date precision: month

Registry last updated2008-03-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Interventions

quetiapine or olanzapine or risperidone or aripiprazoleDRUG

Sponsors & collaborators

Cliniques universitaires Saint-Luc- Université Catholique de Louvainlead sponsor

Mapped research locations

BrusselsBelgium1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00528359 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.